Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients.
D'Huyvetter M, Vos J, Caveliers V, Vaneycken I, Heemskerk J, Duhoux FP, Fontaine C, Vanhoeij M, Windhorst AD, Aa FV, Hendrikse NH, Eersels JLE, Everaert H, Gykiere P, Devoogdt N, Raes G, Lahoutte T, Keyaerts M. D'Huyvetter M, et al. Among authors: hendrikse nh. J Nucl Med. 2021 Aug 1;62(8):1097-1105. doi: 10.2967/jnumed.120.255679. Epub 2020 Dec 4. J Nucl Med. 2021. PMID: 33277400 Free article.
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.
van der Veldt AA, Hendrikse NH, Smit EF, Mooijer MP, Rijnders AY, Gerritsen WR, van der Hoeven JJ, Windhorst AD, Lammertsma AA, Lubberink M. van der Veldt AA, et al. Among authors: hendrikse nh. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1950-8. doi: 10.1007/s00259-010-1489-y. Epub 2010 May 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20508935 Free PMC article. Clinical Trial.
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomography.
van der Veldt AA, Lubberink M, Greuter HN, Comans EF, Herder GJ, Yaqub M, Schuit RC, van Lingen A, Rizvi SN, Mooijer MP, Rijnders AY, Windhorst AD, Smit EF, Hendrikse NH, Lammertsma AA. van der Veldt AA, et al. Among authors: hendrikse nh. Clin Cancer Res. 2011 Jul 15;17(14):4814-24. doi: 10.1158/1078-0432.CCR-10-2933. Epub 2011 Jul 12. Clin Cancer Res. 2011. PMID: 21750197 Free article.
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.
Van der Veldt AA, Lubberink M, Bahce I, Walraven M, de Boer MP, Greuter HN, Hendrikse NH, Eriksson J, Windhorst AD, Postmus PE, Verheul HM, Serné EH, Lammertsma AA, Smit EF. Van der Veldt AA, et al. Among authors: hendrikse nh. Cancer Cell. 2012 Jan 17;21(1):82-91. doi: 10.1016/j.ccr.2011.11.023. Cancer Cell. 2012. PMID: 22264790 Free article. Clinical Trial.
Imaging of TKI-target interactions for personalized cancer therapy.
Poot AJ, Slobbe P, Hendrikse NH, Windhorst AD, van Dongen GA. Poot AJ, et al. Among authors: hendrikse nh. Clin Pharmacol Ther. 2013 Mar;93(3):239-41. doi: 10.1038/clpt.2012.242. Epub 2012 Dec 12. Clin Pharmacol Ther. 2013. PMID: 23340475 No abstract available.
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography.
van der Veldt AA, Lubberink M, Mathijssen RH, Loos WJ, Herder GJ, Greuter HN, Comans EF, Rutten HB, Eriksson J, Windhorst AD, Hendrikse NH, Postmus PE, Smit EF, Lammertsma AA. van der Veldt AA, et al. Among authors: hendrikse nh. Clin Cancer Res. 2013 Aug 1;19(15):4163-73. doi: 10.1158/1078-0432.CCR-12-3779. Epub 2013 Apr 25. Clin Cancer Res. 2013. PMID: 23620410
Radiation dose of the P-glycoprotein tracer 11C-laniquidar.
Postnov A, Froklage FE, van Lingen A, Reijneveld JC, Hendrikse NH, Windhorst AD, Schuit RC, Eriksson J, Lammertsma AA, Huisman MC. Postnov A, et al. Among authors: hendrikse nh. J Nucl Med. 2013 Dec;54(12):2101-3. doi: 10.2967/jnumed.113.120857. Epub 2013 Oct 3. J Nucl Med. 2013. PMID: 24092938 Free article. Clinical Trial.
104 results